[Neuroleptic-antiparkinson corrector antagonism].
D000978:Antiparkinson Agents / Q000009:adverse effects / Q000037:antagonists & inhibitors* / Q000627:therapeutic use; D006801:Humans; D001523:Mental Disorders / Q000188:drug therapy*; D014149:Tranquilizing Agents / Q000009:adverse effects / Q000037:antagonists & inhibitors* / Q000627:therapeutic use
D000978:Antiparkinson Agents; D014149:Tranquilizing Agents
L'antagonisme neuroleptiques -- correcteurs anti-parkinsoniens